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Abstract
Background: Cardiovascular Magnetic Resonance (CMR) of patients with congenital heart disease
(CHD) has become routine clinical practice. However, existing CMR protocols focus
predominantly on patients with ischemic heart disease, and information is limited on the types of
patient with CHD who benefit from CMR investigation, and in what ways. Therefore the aim of
this study was to answer the questions: What type of patients were studied by CMR in a centre
specializing in paediatric and adult CHD management? What questions were asked, which
protocols were used and were the questions successfully answered? To answer these questions,
we conducted a cohort study of all 362 patients that received routine clinical CMR during 2007 at
the Department of Paediatric Cardiology and Congenital Heart Disease at the Deutsches
Herzzentrum München.
Results: Underlying diagnosis was in 33% Fallot's tetralogy, 17% aortic coarctation, 8% Ebstein's
disease, 6% Marfan's disease, 4% single ventricle with Fontan-like circulation, and 32% others.
Median age was 26 years (7 days – 75 years). Ventricular volumes were assessed in 67% of the
patients; flow in 74%; unknown anatomy only in 9%; specific individual morphology of known
anatomy in 83%; myocardial fibrosis in 8%; stress-induced myocardial perfusion defects in 1%. Only
in 3% of the cases the question could not be fully answered.
Conclusion: Contrary to common belief, routine CMR of patients with CHD was not requested
to address global anatomical questions so much as to clarify specific questions of morphology and
function of known anatomy. The CMR protocols used differed markedly from those widely used in
patients with ischemic heart disease.
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Background
Moderate to severe forms of congenital heart disease
(CHD) are found in about 6 of 1,000 live births[1]. All
forms of CHD represent 7 to 19 of 1,000 live births [1-3].
As a result of the success of paediatric cardiology and car-
diac surgery over the last three decades, there will shortly
be more adults than children with CHD[4]. There are cur-
rently estimated to be at least 120,000 adults in Germany
with CHD and this number is expected to rise by about
5,500 per year[5]. The number of patients with complex
forms of CHD are expected to rise by about 50% within
the next few years[6]. A vital component to the multidis-
ciplinary management of the CHD patient is Cardiovascu-
lar Magnetic Resonance (CMR). CMR of patients with
CHD has become routine practice during the last few
years[7]. However, the majority of clinically used CMR
protocols focus on adults with ischemic heart disease and
relatively little information is available on protocols for
patients with CHD[8,9]. Although general guidelines for
CMR of patients with CHD have been developed[7,9,10],
guidelines addressing the range of types of CHD have not.
Nor has the range of CHD questions addressed by routine
clinical CMR been recorded in paediatric and adult
groups, or the duration of imaging, the place of sedation
or anaesthesia, or the contribution of contrast agent. And
most importantly, the clinical value or the ability to
answer the question asked is unknown. Therefore the aim
of this study was to answer the questions: What type of
patients were studied by CMR in paediatric and adult
CHD? What questions were asked, which protocols were
used and were the questions successfully answered? To
address these questions we analyzed the entire cohort of
patients receiving a routine clinical cardiac study in a
CMR-scanner in a large output center dedicated to paedi-
atric and adult CHD during the year 2007.
Results
The main underlying diagnoses were as follows: 121
patients (33%) had Fallot-like hemodynamics after cor-
rection (Fallot's tetralogy, absent pulmonary valve, dou-
ble outlet right ventricle, and pulmonary atresia with or
without a ventricular septal defect status post correction).
61 patients (17%) had aortic coarctation and/or aortic
arch anomalies (native, status post surgery, or status post
surgery and catheter intervention). 30 patients (8%) had
Ebstein's disease (native or status post surgery). 23
patients (6%) had Marfan's syndrome or other types of
aortic dilatation (native or status post surgery). 16
patients (4%) had Fontan-like circulation (different types
of right atrium to pulmonary artery anastomosis or total
cavopulmonary connection with intracardiac or extracar-
diac tunnel). 16 patients (4%) had congenital aortic valve
or supravalvular aortic stenosis (native or status post aor-
tic valve dilatation or Ross operation). The remaining 95
patients (28%) had other underlying diagnoses [see addi-
tional file 1].
Median age for the entire cohort was 26 years (7 days – 75
years). Median weight was 64 kg (2.3 – 122 kg).
Median scan duration for the whole cohort was 47 min (2
– 110 min).
The majority of patients (n = 347, 96%) did not require
sedation or intubation. Four patients (1%) required seda-
tion without intubation. The median age of these four
patients was 40 days (7 days – 2.4 months). The median
scan duration of these four patients was 35 min (16 – 49
min). Eleven patients (3%) required anesthesia with intu-
bation. The median age of these eleven patients was 3.3
years (15 days – 5.8 years). The median scan duration of
these eleven patients was 38 min (20 – 131 min).
228 patients (63%) received contrast agent.
The questions asked were successfully answered in 350
patients (97%). The questions asked were only partially
answered in five patients (1%), and not answered in seven
patients (2%).
The reasons for an unsuccessful CMR-study were coil-arte-
facts (n = 3), arrhythmia (n = 2), unreliable ECG- or pulse-
wave-triggering (n = 2), stent-artefacts in a patient with
coarctation of the aorta (n = 1), impossible positioning of
a patient with extreme scoliosis (n = 1), a previously unde-
tected retrocardial surgical needle (n = 1), unconclusive
flow and morphology results (n = 1), and claustrophobia
(n = 1).
Ventricular volumes were assessed in 241 patients (67%).
Flow was assessed in 267 patients (74%). Median number
of flow measurements per patient was two (0 – 6). One
flow measurement was carried out in 30 patients (8%),
two flow measurements in 72 patients (20%), three flow
measurements in 18 patients (5%), four flow measure-
ments in 132 patients (36%), five flow measurements in
eight patients (2%), and six flow measurements in seven
patients (2%).
Unknown anatomy was assessed only in 31 patients
(9%).
Specific individual morphology of known anatomy was
assessed in 299 patients (83%).
Myocardial fibrosis was assessed only in 29 patients (8%).Journal of Cardiovascular Magnetic Resonance 2008, 10:46 http://www.jcmr-online.com/content/10/1/46
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Stress-induced myocardial perfusion defects were assessed
only in three patients (1%).
Methods
The study cohort consisted of all 362 patients that
received routine clinical CMR between Januray, 1st and
December, 31st, 2007 at the Department of Paediatric Car-
diology and Congenital Heart Disease at the Deutsches
Herzzentrum München.
A standard cardiac 1.5 Tesla MRI-scanner and a standard
cardiac 12-channel coil were used for all patients (MAG-
NETOM Avanto®, Siemens Healthcare, Erlangen, Ger-
many). A standard MR-compatible anaesthesia monitor
(Invivo, Orlando, USA) was used to continuously moni-
tor ECG, blood pressure, transcutaneous saturation,
exhaled CO2 of all patients during anaesthesia with intu-
bation or sedation without intubation.
All CMR reports of the entire cohort were retrospectively
reviewed.
The following parameters were analysed: diagnosis, age,
weight in kg, use of sedation or intubation, scan-duration
defined as time between first and last scan, use of contrast
agent (gadopentetate dimeglumine, Magnevist®, Bayer
Health Care, Leverkusen, Germany), sequences used and
the ability to answer the questions asked.
According to the question asked, as documented on the
CMR report, we defined six types of questions to be
answered: (1) Ventricular volumes, e.g. right ventricular
end diastolic volume for the evaluation of patients with
repaired Fallot's tetralogy. (2) Flow through a vessel, e.g.
forward and backward flow through the pulmonary artery
for calculation of pulmonary regurgitation for the evalua-
tion of patients with repaired Fallot's tetralogy. (3)
Unknown anatomy, e.g. search for veno-venous collater-
als late after Fontan-type surgery. (4) Specific individual
morphology of known anatomy, e.g. imaging of hom-
ograft morphology for planning percutaneous pulmonary
valve implantation. (5) Presence of myocardial fibrosis,
e.g. status post coronary event. (6) Presence of stress-
induced myocardial perfusion defect, e.g. evaluation of
chest pain status post coronary artery surgery. By grouping
the sequences used according to the question to be
answered, we therefore defined six protocols. (1) ventricu-
lar volume protocol (using multiphased, multislice cine
SSFP sequences in axial or short axis orientation, temoral
resolution: 20–40 ms, slice thickness: 4–6 mm), (2) flow
protocol (using phase-encoded multiphased sequences,
free breathing, retrospective ECG-gating, velocity encod-
ing 150–500 cm/s), (3) unknown anatomy protocol
(using 3-dimensional navigator- and ECG-triggered SSFP
sequences, contrast enhanced angiography, and mul-
tiphased cine SSFP sequences), (4) specific individual
morphology of known anatomy protocol (using 3-dimen-
sional navigator- and ECG-triggered SSFP sequences, con-
trast enhanced angiography, and multiphased cine SSFP
sequences), (5) myocardial fibrosis protocol (using Late
Gadolinium Enhancement sequences), and (6) stress-
induced myocardial perfusion defect protocol (using ade-
nosin-stress-perfusion sequences).
The question asked, as documented on the CMR report,
was defined as successfully answered according to the
conclusion, as documented on the CMR report. If only
parts of the question asked were successfully answered
(e.g. successful volume analysis but unsuccessful flow
analysis), the question was defined as partially answered.
If during the retrospective analysis there was a doubt, that
the answer asked was not successfully answered, the ques-
tion was defined as not answered.
Discussion
The results of this review of clinical practice study show
that the largest patient group (33% of all patients) studied
in a CMR system dedicated largely to CHD were young
adults with Fallot-like hemodynamics after repair (Fallot's
tetralogy, absent pulmonary valve, double outlet right
ventricle, and pulmonary atresia with or without a ven-
tricular septal defect status post correction). The second
largest group (17%) were young adults with coarctation of
the aorta or other aortic arch anomalies before or after sur-
gery. These two groups accounted for half of the patients.
The other half consisted of a heterogenous group of
patients [see additional file 1].
The results of this study show that in two thirds of the
cases quantification of ventricular volumes was amongst
the questions asked [see additional file 1] and in three
quarters, quantification of blood flow was requested. This
contrasts with CMR imaging in patients with acquired
heart disease [7,9] who, except in the presence of valvular
heart disease, rarely require quantification of blood
flow[8,9].
Furthermore, the results show that investigation of myo-
cardial fibrosis or stress-induced myocardial perfusion
defects was rarely requested, again in contrast to patients
with acquired heart disease [8,9]. However, this may
reflect our own experience [11], that fibrosis is not a com-
mon finding in patients with CHD.
Another important result of this study is that unknown
anatomy was rarely (9%) a question asked in the study
cohort. However, specific individual morphology of
known anatomy was the most commonly asked question
(83%). These findings support the previously stated
hypothesis [12-14] that CMR in paediatric and adult CHDJournal of Cardiovascular Magnetic Resonance 2008, 10:46 http://www.jcmr-online.com/content/10/1/46
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is a tool for answering questions regarding specific indi-
vidual morphology and hemodynamic function of known
anatomy. This is in contrast to the perception that the pri-
mary goal of CMR in paediatric and adult CHD is to
describe the location and anatomy of a congenital heart
defect [15-18].
We also found that the overwhelming majority (97%) of
all cases the questions asked were successfully answered
by the CMR study.
In our series, one CMR-study could not be completed due
to a previously undetected retrocardial surgical needle.
After positioning the patient in the magnet, the scout
sequences showed a large artifact for which no external
explanation was found. A standard chest x-ray revealed a
retrocardiac surgical needle. A retrospective review of the
report of the operation 24 years previously in another hos-
pital showed that the missing needle had been mentioned
but could not be retrieved during the operation.
An important limitation of our study is that the study
cohort reflects the specific situation in our center, the find-
ings may not necessarily be applicable to other CHD cent-
ers. At our hospital (Deutsches Herzzentrum München)
all paediatric patients with cardiac problems and all
patients with CHD regardless of age are treated in a single
Department of Paediatric Cardiology and Congenital
Heart Disease, whereas it may be common practice for
paediatric and adult patients to be managed in different
departments. Our center may also differ from other cent-
ers in two further points. Firstly, in the larger Munich area
close pre- and postnatal echocardiography is available
and diagnosis and anatomy were usually well established
by the first visit. Secondly, our patients are closely fol-
lowed up throughout life and their anatomy continues to
be well documented. Potential further differences to other
centers may be related to our CMR service. Our hospital
has one 1.5T MRI-scanner (MAGNETOM Avanto®, Sie-
mens Healthcare, Erlangen, Germany). The scanner was
used by all three departments of our hospital (Depart-
ment of Paediatric Cardiology and Congenital Heart Dis-
ease, Department of Cardiology, and Department of
Cardiac Surgery). The scanner was used for clinical and
research questions. The scanner was used for cardiac imag-
ing and also non-cardiac imaging (e.g. pre-/post OP imag-
ing of the brain). The patients were booked at intervals
through the day depending on the estimated scan time, all
patients from the Department of Paediatric Cardiology
and Congenital Heart Disease (cohort of this study) being
booked hourly. On each working day two patients from
the Department of Paediatric Cardiology and Congenital
Heart Disease were booked well in advance (our current
waiting list is three to four months). Up to two further
cases a day from the Department of Paediatric Cardiology
and Congenital Heart Disease could be scheduled at short
notice to address more urgent questions. The cohort of
this study (n = 362) represented 26% of all patients
scanned during 2007. Of note, the scan time of patients in
this cohort was longer than most other patient cohorts,
therefore the estimated total scan duration of the cohort
of this study represented about 40% of total scan time
during 2007. Postprocessing the data was also time-con-
suming, taking about one hour of postprocessing- and
reporting-time per patient and requiring expertise in both
CHD and CMR. Our set-up consisted of one expert in
CHD and CMR (SF or HS), a trainee (AS or CB), and a
technician. The expert in CHD and CMR planned the
study, was responsible for the patient information and
consent form, was present during the whole study, and
wrote the report. The trainee was an interested beginner in
CHD and well-trained in volume and flow analysis. The
trainee analysed the volume and flow studies on a sepa-
rate work station during the on-going study. The techni-
cian rotated to the scanner from a pool of technicians with
variable knowledge of CHD and CMR. The results of the
studies were presented the following working day by the
expert in CHD and CMR on a daily conference including
presentation of other imaging modalities. For these con-
ferences the expert in CHD and CMR presented the data
and the images using a dedicated work station and projec-
tor.
Only a relatively small subgroup of patients (n = 15/362,
4%) required anaesthesia with intubation, or sedation
without intubation. Therefore, the relative safety of anaes-
thesia with intubation or sedation without intubation
cannot be deduced from the numbers available. Not all
clinicians would necessarily accept that sedation of non-
intubated patients with CHD is acceptably safe when
imaging in the confines of a magnet. On the other hand
however, not all clinicians would necessarily accept that
intubation of a patient is justified for a short non-invasive
study that does not necessarily require interruption of free
breathing. The decision to carry out CMR under anaesthe-
sia with intubation or sedation without intubation was
based on three points at our center: the need for acquisi-
tion during interrupted breathing, the expected compli-
ance of the patient and the preference of the
anaesthesiologist. The expert in CHD and CMR (SF or HS)
decided first after speaking with the parent of the patient
if the CMR could be carried out without any form of
anaesthesia or sedation. If this was not the case, he
decided, depending on the need for breath holds and the
anticipated length of the study, if anaesthesia with intuba-
tion or sedation without intubation was needed. He then
reached a final decision with the responsible anaesthesiol-
ogist.Journal of Cardiovascular Magnetic Resonance 2008, 10:46 http://www.jcmr-online.com/content/10/1/46
Page 5 of 6
(page number not for citation purposes)
Conclusion
Taken together, the results of this study show that patients
referred to CMR in paediatric and adult CHD had already
been evaluated anatomically, and the main reasons for
referral for CMR were questions regarding specific individ-
ual morphology and function of known anatomy.
This cohort study of patients receiving a routine clinical
CMR study in a scanner dedicated to paediatric and adult
CHD in 2007 may provide a basis for hospital planners
and the CMR industry to understand the needs of patients
with CHD.
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